GlassScriptPhysician profile
Rajit Saluja
NPI 1467550491
$19,292.89
in general payments reported to CMS, 2019-2025
9 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,940 · 2020: $1,033 · 2022: $1,666 · 2023: $12K · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,881 · Travel and Lodging: $2,980 · Food and Beverage: $773 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,880.50 |
| Travel and Lodging | $2,980.22 |
| Food and Beverage | $773.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,131.86 | 2019-2025 | Arthrex |
| Great Lakes Orthopedics | $3,514.58 | 2019-2022 | |
| Enduromed, LLC | $181.54 | 2023 | |
| Amgen INC. | $130.40 | 2025 | Evenity |
| Zimmer Biomet Holdings, INC. | $113.86 | 2023 | |
| Convatec INC. | $89.22 | 2022 | |
| Allergan, INC. | $59.93 | 2019 | |
| Stryker Corporation | $56.18 | 2020 | |
| Kerecis Limited | $15.32 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajit Saluja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.